Mitochondrial mutations and metabolic adaptation in pancreatic cancer
{{output}}
Background: Pancreatic cancer has a five-year survival rate of ~8%, with characteristic molecular heterogeneity and restricted treatment options. Targeting metabolism has emerged as a potentially effective therapeutic strategy fo... ...
